The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL

被引:19
作者
Barna, Gabor [1 ]
Reiniger, Lille [1 ]
Tatrai, Peter [2 ]
Kopper, Laszlo [1 ]
Matolcsy, Andras [1 ]
机构
[1] Semmelweis Univ, Fac Med, Dept Pathol & Expt Canc Res, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Fac Med, Dept Pathol, H-1085 Budapest, Hungary
关键词
CLL; MCL; CD23; flow cytometry;
D O I
10.1002/hon.855
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Flow cytometric analysis of CD23 expression in CD5-positive B-cells is a widely applied method in the differential diagnosis of chronic lymphocytic leukaemia (CLL) and mantle cell lymphoma (MCL). According to the most accepted criteria, the leukaemic cell population is CD19/CD5/CD23 triple positive in CIA, but CD23-negative in MCL. Recently, several groups have reported CD23-positive MCL cases; however, these studies mostly analysed only CD23 positivity but not intensity. To determine the role and the cut-off levels of CD23 positivity and intensity in the differential diagnosis of CLL and MCL, 26 cases of MCL and 84 cases of CLL were compared using flow cytometric analysis. Our results suggest that high values of CD23 positivity (> 92.5%) and/or high fluorescence intensity (> 44.5 mean fluorescence intensity (MFI)) of CD23 are related to CLL, whereas low CD23 positivity (< 30%) is related to MCL. However, cases with intermediate CD23 positivity (between 30 and 92.5%) and lower intensity (< 44.5 MFI) can either belong to CLL or MCL. In these cases, additional tests such as FISH analysis of the translocation t(11;14) or immunohistochemical detection of cyclin D1 overexpression are required to differentiate CLL from MCL. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 18 条
  • [1] Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification
    Ahmad, E
    Garcia, D
    Davis, BH
    [J]. CYTOMETRY, 2002, 50 (01): : 1 - 7
  • [2] [Anonymous], 2001, PATHOLOGY GENETICS T
  • [3] BOSCH F, 1994, BLOOD, V84, P2726
  • [4] Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias
    Cro, L
    Guffanti, A
    Colombi, M
    Cesana, B
    Grimoldi, MG
    Patriarca, C
    Goldaniga, M
    Neri, A
    Intini, D
    Cortelezzi, A
    Maiolo, AT
    Baldini, L
    [J]. LEUKEMIA, 2003, 17 (01) : 125 - 132
  • [5] The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease
    DiRaimondo, F
    Albitar, M
    Huh, Y
    O'Brien, S
    Montillo, M
    Tedeschi, A
    Kantarjian, H
    Lerner, S
    Giustolisi, R
    Keating, M
    [J]. CANCER, 2002, 94 (06) : 1721 - 1730
  • [6] DORFMAN DM, 1994, MODERN PATHOL, V7, P326
  • [7] FOURNIER S, 1994, BLOOD, V84, P1881
  • [8] Garcia DP, 2001, AM J CLIN PATHOL, V115, P258
  • [9] Levels of expression of CD19 and CD20 in chronic B cell leukaemias
    Ginaldi, L
    De Martinis, M
    Matutes, E
    Farahat, N
    Morilla, R
    Catovsky, D
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1998, 51 (05) : 364 - 369
  • [10] Gong JZ, 2001, AM J CLIN PATHOL, V116, P893